Search for: All records

Bacterial cellulose (BC) is a versatile biopolymer with significant potential across biomedical, food, and industrial applications. To remove bacterial contaminants, such as protein and DNA, BC pellicles undergo purification, which traditionally relies on harsh alkali treatments, such as sodium hydroxide or strong surfactants, which present environmental concerns. In response, this study evaluates the efficacy of various non-conventional surfactants—both non-biodegradable and biodegradable—as alternatives for BC purification. Among the surfactants tested, sodium cocoyl isethionate (SCI), a mild anionic and biodegradable surfactant, emerged as particularly effective, achieving an 80.7% reduction in protein content and a 65.19% reduction in double-stranded DNA (dsDNA) content relative to untreated samples. However, these advantages were not without additional challenges, such as the appearance of residual surfactants. Given SCI’s promising performance and biodegradability, it was further examined in two-step treatment protocols; additionally, sodium dodecyl sulfate (SDS) was also examined as a more traditional anionic surfactant as well as NaOH. For the two-step treatment protocol, BC pellicles were treated with one reagent for 3 h, followed by a second reagent for an additional 3 h. Notably, by using NaOH as the final step in the two-step treatment protocol, residual surfactant was not detected in the FTIR analysis. Overall, this work demonstrates that SCI, in addition to subsequent NaOH treatment, can be used as a surfactant-based approach for BC purification, representing a potential environmentally friendly alternative to traditional surfactant-based approaches for BC purification. 

Bacterial-derived cellulose (BC) has been studied as a promising material for biomedical applications, including wound care, due to its biocompatibility, water-holding capacity, liquid/gas permeability, and handleability properties. Although BC has been studied as a dressing material for cutaneous wounds, to date, BC inherently lacks antibacterial properties. The current research utilizes bifunctional chimeric peptides containing carbohydrate binding peptides (CBP; either a short version or a long version) and an antimicrobial peptide (AMP), KR-12. The secondary structure of the chimeric peptides was evaluated and confirmed that the α-helix structure of KR-12 was retained for both chimeric peptides evaluated (Long-CBP-KR12 and Short-CBP-KR12). Chimeric peptides and their individual components were assessed for cytotoxicity, where only higher concentrations of Short-CBP and longer timepoints of Short-CBP-KR12 exposure exhibited negative effects on metabolic activity, which was attributed to solubility issues. All KR-12-containing peptides exhibited antibacterial activity in solution against Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa). The lipopolysaccharide (LPS) binding capability of the peptides was evaluated and the Short-CBP-KR12 peptide exhibited enhanced LPS-binding capabilities compared to KR-12 alone. Both chimeric peptides were able to bind to BC and were observed to be retained on the surface over a 7-day period. All functionalized materials exhibited no adverse effects on the metabolic activity of both normal human dermal fibroblasts (NHDFs) and human epidermal keratinocyte (HaCaT) epithelial cells. Additionally, the BC tethered chimeric peptides exhibited antibacterial activity against E. coli. Overall, this research outlines the design and evaluation of chimeric CBP-KR12 peptides for developing antimicrobial BC membranes with potential applications in wound care.